Skip to main content
Year archive

Celyad Oncology SA — 2021 filings

All 69 regulatory filings released by Celyad Oncology SA (CYAD) in 2021, sourced directly from the official regulator.

69 Filings
2021 Period
2021 filings (69)
Filing Released Lang
2021-12-31-CYAD-Increase-of-Outstanding-ordinary-shares_EN1.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-12-31 English
2021-12-31-CYAD-Increase-of-Outstanding-ordinary-shares_FR1.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-12-31 French
Art.14-Transparency-notification-Tolefi_EN.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-12-17 English
Art.14-Transparency-notification-Tolefi_FR.pdf
Major Shareholding Notification
2021-12-17 French
Art.14 Transparency notification Fortress_EN_FINAL.pdf
Major Shareholding Notification
2021-12-15 English
Art.14 Transparency notification Fortress_FR FINAL.pdf
Major Shareholding Notification
2021-12-15 French
Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition
Earnings Release Q4 2021
2021-12-13 English
Celyad Oncology présente des mises à jour sur les programmes CAR-T basés sur la technologie ARNsh lors de la 63e assemblée et exposition annuelles de l’ASH
AGM Information
2021-12-13 French
Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate
Capital/Financing Update
2021-12-08 English
Celyad Oncology annonce la clôture du placement privé de 32,5 millions USD souscrit par une filiale de Fortress Investment Group
Share Issue/Capital Change
2021-12-08 French
Celyad - E&Y report 2021208.pdf
Audit Report / Information FY 2021
2021-12-08 French
Celyad - Notarized deed 20211208.pdf
Capital/Financing Update
2021-12-08 French
Celyad - Board report 20211208.pdf
Share Issue/Capital Change
2021-12-08 French
Celyad Oncology Announces $32.5 Million Private Placement with Fortress Investment Group
Capital/Financing Update
2021-12-03 English
Celyad Oncology annonce un placement privé de 32,5 millions de dollars souscrit par Fortress Investment Group
Capital/Financing Update
2021-12-03 French
Celyad Oncology Q3 2021_EN_.pdf
Earnings Release Q3 2021
2021-11-10 English
Celyad Oncology Q3 2021_FR_v1.pdf
Earnings Release Q3 2021
2021-11-10 French
2021-10-29 - CYAD - Increase of Outstanding ordinary shares_EN.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-10-29 English
2021-10-29 - CYAD - Increase of Outstanding ordinary shares_FR_V1.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-10-29 French
Celyad Oncology First Half 2021 Financials_FINAL_EN.pdf
Interim / Quarterly Report H1 2021
2021-08-04 English
Celyad Oncology First Half 2021 Financials_FINAL_FR.pdf
Interim / Quarterly Report H1 2021
2021-08-04 French
Celyad Oncology - Interim Financial Report - 20210804 - EN - FINAL.pdf
Interim / Quarterly Report H1 2021
2021-08-04 English
Celyad - RAPPORT FINANCIER INTERMEDIAIRE_2021 - 20210804 - FR - FINAL.pdf
Interim / Quarterly Report H1 2021
2021-08-04 French
2021-07-30 - CYAD - Increase of Outstanding ordinary shares_EN_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-07-30 English
2021-07-30 - CYAD - Increase of Outstanding ordinary shares_FR_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-07-30 French
2021-06-30 - CYAD - Increase of Outstanding ordinary shares_EN_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-06-30 English
2021-06-30 - CYAD - Increase of Outstanding ordinary shares_FR_FINAL.pdf
Share Issue/Capital Change
2021-06-30 French
21 Celyad Oncology - Report Accounting and financial info 21 - FR.pdf
Legal Proceedings Report
2021-06-28 French
20210628_Acte notarié du conseil d’administration.pdf
Capital/Financing Update
2021-06-28 French
20210628_Rapport du CA Celyad Oncology.pdf
Share Issue/Capital Change
2021-06-28 French
2021-05-31 - CYAD - Increase of Outstanding ordinary shares_EN_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-31 English
2021-05-31 - CYAD - Increase of Outstanding ordinary shares_FR_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-31 French
PV AGE 25mai2021.pdf
AGM Information
2021-05-25 French
Transparency notification Victory Capital Management_EN_Final.pdf
Director's Dealing
2021-05-19 English
Transparency notification Victory Capital Management Inc_FR_FINAL.pdf
Director's Dealing
2021-05-19 French
Celyad Oncology Q1 2021_EN_Final.pdf
Earnings Release Q1 2021
2021-05-06 English
Celyad Oncology Q1 2021_FR_Final.pdf
Earnings Release Q1 2021
2021-05-06 French
PV AGO 20210505_EN FINAL.pdf
AGM Information
2021-05-05 English
PV AGO 20210505 FR FINAL.pdf
AGM Information
2021-05-05 French
Transparency Notification_TolefiSA__04052021.pdf
Major Shareholding Notification
2021-05-05 English
Transparency notification Tolefi SA EN_FSMA.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-05 English
Transparency notification Tolefi SA FR_FSMA.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-05 French
2021-05-04 - CYAD - double voting rights_ EN_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-04 English
2021-05-04 - CYAD - double voting rights_ FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-04 French
PV Celyad 29-4-2021.pdf
Capital/Financing Update
2021-04-30 French
rapport CdA.pdf
Share Issue/Capital Change
2021-04-30 French
rapport commissaire.pdf
Share Issue/Capital Change
2021-04-30 French
2021-04-21 - CYAD - Increase of Outstanding ordinary shares_EN_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-04-30 English
2021-04-21 - CYAD - Increase of Outstanding ordinary shares_FR_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-04-30 French
CA_Acte d'émission.pdf
Capital/Financing Update
2021-04-09 French
Rapport du CA.pdf
Governance Information
2021-04-09 French
E&Y Report Accounting and financial info.pdf
Share Issue/Capital Change
2021-04-09 French
Rapport de gestion 2020 FR Celyad Oncology S.A - 20210324 - signed.pdf
Management Reports FY 2020
2021-04-02 French
2021-03-29 - CYAD - Increase of Outstanding ordinary shares_EN_FINAL_.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 English
2021-03-29 - CYAD - Increase of Outstanding ordinary shares_FR_FINAL_.pdf
Share Issue/Capital Change
2021-03-31 French
PR Celyad FY2020 - ENGLISH - FINAL - 03242021.pdf
Earnings Release FY 2020
2021-03-24 English
PR Celyad FY2020 - FRENCH - FINAL - 03242021_.pdf
Interim / Quarterly Report FY 2020
2021-03-24 French
PR Celyad FY2020 - ENGLISH - FINAL - 03242021.pdf
Earnings Release FY 2020
2021-03-24 English
PR Celyad FY2020 - FRENCH - FINAL - 03242021.pdf
Earnings Release FY 2020
2021-03-24 French
CELYAD - Annual Report 2020 - EN - 2021_03_24 Final.pdf
Annual Report FY 2020
2021-03-24 English
CELYAD_Rapport Annuel 2020_FR_20210325 - FINAL.pdf
Annual Report FY 2020
2021-03-24 French
Celyad Oncology - Jan 2021_Shares (art.15)_EN.pdf
Share Issue/Capital Change
2021-01-20 English
Celyad Oncology - Jan 2021_Shares (art.15)_FR_.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-01-20 French
Rapport spécial du CA 8 janvier 2021.pdf
Share Issue/Capital Change
2021-01-07 French
20210108_CA_LPC.pdf
Capital/Financing Update
2021-01-07 French
20 Celyad Oncology - Rapport d'evaluation sur les données comptables en financières - Project Cello.pdf
Audit Report / Information FY 2021
2021-01-07 French
Celyad Oncology Announces Equity Purchase Agreement for up to USD40 Million with Lincoln Park Capital
Capital/Financing Update
2021-01-07 English
Celyad Oncology Announces Equity Purchase Agreement for up to USD40 Million with Lincoln Park Capital
Share Issue/Capital Change
2021-01-07 French
Celyad Oncology Announces Equity Purchase Agreement for up to USD40 Million with Lincoln Park Capital
Capital/Financing Update
2021-01-07 Dutch